Chao TY - Search Results

1

Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.

Hsu C, Huang CS, Chao TY, Lu YS, Bu CF, Chen MM, Chang KJ, Cheng AL. Hsu C, et al. Among authors: chao ty. Cancer. 2002 Nov 15;95(10):2044-50. doi: 10.1002/cncr.10951. Cancer. 2002. PMID: 12412156 Free article. Clinical Trial.

2

Extragonadal germ cell tumors in Taiwan: an analysis of treatment results of 59 patients.

Hsu YJ, Pai L, Chen YC, Ho CL, Kao WY, Chao TY. Hsu YJ, et al. Among authors: chao ty. Cancer. 2002 Aug 15;95(4):766-74. doi: 10.1002/cncr.10738. Cancer. 2002. PMID: 12209720 Free article.

3

Phase II study of paclitaxel (Genaxol) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer (NSCLC).

Chen CH, Chang WC, Lin MC, Hsu JW, Chao TY, Tsao TC. Chen CH, et al. Among authors: chao ty. Lung Cancer. 2002 Oct;38(1):91-6. doi: 10.1016/s0169-5002(02)00148-4. Lung Cancer. 2002. PMID: 12367799 Clinical Trial.

4

Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma.

Huang CL, Lin ZZ, Su IJ, Chao TY, Tien HF, Chang MC, Huang MC, Kao WY, Tang JL, Yeh KH, Wang CH, Hsu CH, Liu MY, Cheng AL. Huang CL, et al. Among authors: chao ty. Leuk Lymphoma. 2002 Jul;43(7):1415-20. doi: 10.1080/1042819022386806. Leuk Lymphoma. 2002. PMID: 12389622 Clinical Trial.

5

Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.

Cheng AL, Hsiung CA, Su IJ, Chen PJ, Chang MC, Tsao CJ, Kao WY, Uen WC, Hsu CH, Tien HF, Chao TY, Chen LT, Whang-Peng J; Lymphoma Committee of Taiwan Cooperative Oncology Group. Cheng AL, et al. Among authors: chao ty. Hepatology. 2003 Jun;37(6):1320-8. doi: 10.1053/jhep.2003.50220. Hepatology. 2003. PMID: 12774010 Clinical Trial.

6

Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study.

Dai MS, Wu PF, Lu JJ, Shyu RY, Chao TY. Dai MS, et al. Among authors: chao ty. Support Care Cancer. 2004 Mar;12(3):191-6. doi: 10.1007/s00520-003-0549-2. Support Care Cancer. 2004. PMID: 15074316

7

Catastrophic heparin-induced thrombocytopenia/thrombosis syndrome related to the use of a Port-A-Cath in a breast cancer patient receiving chemotherapy.

Dai MS, Hsieh AT, Chao TY. Dai MS, et al. Among authors: chao ty. Support Care Cancer. 2004 Jul;12(7):537-9. doi: 10.1007/s00520-004-0631-4. Epub 2004 Apr 28. Support Care Cancer. 2004. PMID: 15114479

8

Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.

Chao TY, Ho CL, Lee SH, Chen MM, Janckila A, Yam LT. Chao TY, et al. J Biomed Sci. 2004 Jul-Aug;11(4):511-6. doi: 10.1007/BF02256100. J Biomed Sci. 2004. PMID: 15153786

9

Oxaliplatin added to simplified bimonthly low-dose leucovorin and 5-FU for pretreated advanced colorectal cancer is effective and not affected by different previous 5-FU regimens.

Hsieh RK, Chao TY, Chen WS, Yang TS, Chen LT, Chen PM, Liu JH. Hsieh RK, et al. Among authors: chao ty. Cancer Invest. 2004;22(2):171-9. doi: 10.1081/cnv-120030204. Cancer Invest. 2004. PMID: 15199598 Clinical Trial.

10

Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.

Chao TY, Yu JC, Ku CH, Chen MM, Lee SH, Janckila AJ, Yam LT. Chao TY, et al. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):544-50. Clin Cancer Res. 2005. PMID: 15701839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters